Challenger (ASX:CGF) said that TAL Dai-ichi Life Australia informed the firm that it completed the acquisition of a 19.9% stake in the firm, according to a Friday Australian bourse filing.
It previously received the necessary regulatory approvals, including from the Australian Prudential Regulation Authority, for the acquisition.